<SEC-DOCUMENT>0001193125-26-154882-index.html : 20260414
<SEC-HEADER>0001193125-26-154882.hdr.sgml : 20260414
<ACCEPTANCE-DATETIME>20260414160610
ACCESSION NUMBER:		0001193125-26-154882
CONFORMED SUBMISSION TYPE:	8-A12B
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20260414
DATE AS OF CHANGE:		20260414

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Kailera Therapeutics, Inc.
		CENTRAL INDEX KEY:			0002096997
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-A12B
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-43233
		FILM NUMBER:		26860882

	BUSINESS ADDRESS:	
		STREET 1:		180 THIRD AVENUE
		STREET 2:		4TH FLOOR
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
		BUSINESS PHONE:		508-440-9475

	MAIL ADDRESS:	
		STREET 1:		180 THIRD AVENUE
		STREET 2:		4TH FLOOR
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-A12B
<SEQUENCE>1
<FILENAME>d138694d8a12b.htm
<DESCRIPTION>8-A12B
<TEXT>
Document 1 - file: d138694d8a12b.htm

</DOCUMENT>
</SEC-DOCUMENT>